<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-15.7-a.7'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//ph-ksp.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://ph-ksp.com/neuroinflammation-blood-brain-barrier-dysfunction-and-cognitive-decline-in-pulmonary-arterial-hypertension-an-experimental-study-scientif-reports-nature-april-3-2026/</loc>
  <lastmod>2026-04-04T15:55:20Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Neuroinflammation, blood-brain barrier dysfunction, and cognitive decline in pulmonary arterial hypertension: an experimental study, Scientific Reports, Nature, April 3, 2026</news:title>
   <news:publication_date>2026-04-04T15:19:38Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://ph-ksp.com/new-blood-markers-show-promise-for-group-2-pulmonary-hypertension-pulmonary-hypertension-news-march-23-2026/</loc>
  <lastmod>2026-04-04T11:29:11Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>New blood markers show promise for World Health Organisation (WHO) Group 2 pulmonary hypertension, Pulmonary Hypertension News, March 23, 2026</news:title>
   <news:publication_date>2026-04-04T11:28:14Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://ph-ksp.com/cereno-scientific-reports-favorable-safety-and-tolerability-after-12-months-of-cs1-treatment-in-pulmonary-arterial-hypertension-pahfrom-the-expanded-access-program-eap-march-31-2026/</loc>
  <lastmod>2026-04-04T11:31:47Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Cereno Scientific reports favorable safety and tolerability after 12 months of CS1 treatment in pulmonary arterial hypertension (PAH)from the Expanded Access Program (EAP), March 31, 2026</news:title>
   <news:publication_date>2026-04-04T11:19:23Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://ph-ksp.com/congenital-heart-disease-and-pulmonary-arterial-hypertension-current-perspectives-review-of-cardiovascular-medicine-march-20-2026/</loc>
  <lastmod>2026-04-04T10:57:50Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Congenital Heart Disease and Pulmonary Arterial Hypertension: Current Perspectives, Review of Cardiovascular Medicine, March 20, 2026</news:title>
   <news:publication_date>2026-04-04T10:57:48Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://ph-ksp.com/the-new-us-food-and-drug-administration-fdas-guidance-paper-on-incorporating-voluntary-patient-preference-information-over-the-total-product-cycle-and-what-it-means-for-patient-organisations-mar/</loc>
  <lastmod>2026-04-04T11:08:57Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>The new US Food and Drug Administration (FDA)&amp;#039;s guidance paper on incorporating voluntary patient preference information over the total product cycle, and what It means for patient organisations, March 30, 2026</news:title>
   <news:publication_date>2026-04-04T09:26:43Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://ph-ksp.com/telemedicine-trends-post-covid-19-journal-of-internal-general-medicine-february-11-2026/</loc>
  <lastmod>2026-04-04T11:03:35Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Telemedicine trends post Covid-19, Journal of Internal General Medicine, February 11, 2026</news:title>
   <news:publication_date>2026-04-04T08:30:47Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
